Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Underestimated Metropolitan Experience Urban communities On the planet - 2The Incomparable Advanced cameras: Which One Will Win?
- 3Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- 4Famous Restroom Beautifying Styles For 2024
- 5Keep It Cool: Uncovering Famous Fridge Brands for Each Home
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- My skin feels drier, my lips thinner and my makeup heavier. How do I adjust my routine for aging skin?
- Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- Vote In favor of Your Number one Cell phones
- Vote in favor of Your Number one kind of pie
- Famous SUVs With Low Energy Utilization In 2024
- New science points to 4 distinct types of autism
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
